DUBLIN--(BUSINESS WIRE)--The "Global Bio CMO Market: Size, Trends & Forecasts (2018 Edition)" report has been added to ResearchAndMarkets.com's offering.
The global bio CMO market has shown upward trends over the past few years and is anticipated to follow the same trend in the coming years as well. The market is expected to rise at a significant growth rate over the forecasted period (2018-2022).
Growth drivers, such as increase in pharmaceutical industry, potential biologics blockbusters, introduction of targeted therapins, grater outsourcing demand from global pharmas, etc. will help the market to grow.
Lonza Group, Boehringer Ingelheim, Samsung Biologics and Wuxi Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.
Key Topics Covered
1. Executive Summary
2. Introduction
2.1 Pharmaceutical Industry Overview
2.2 Biotechnology
Biologics Overview
2.3 Biosimilar Overview
2.4 Biologics/Biosimilar Manufacturing
2.5 Bio CMO Overview
3. Global Market Analysis
3.1 Global Biologics Market Analysis
3.2 Global Biologics Manufacturing Market Analysis
3.3 Global Bio CMO Market Analysis
3.4 Global Bio CMO Market Segment Analysis
4. Competitive Landscape
4.1 Global Bio CMO Players by Capacity
4.2 Global Bio CMO Market Players Financial Comparison
5. Company Profiles
5.1 Lonza Group
5.2 Boehringer Ingelheim
5.3 Samsung Electronics (Samsung Biologics)
5.4 Wuxi Biologics
For more information about this report visit https://www.researchandmarkets.com/research/q5jmb7/global_bio_cmo?w=4
